Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With Prolactinoma
Condition(s):Pituitary Adenoma; Prolactinoma; Pituitary Tumor; Recurrence TumorLast Updated:March 18, 2020Recruiting
Hide Studies Not Open or Pending
Condition(s):Pituitary Adenoma; Prolactinoma; Pituitary Tumor; Recurrence TumorLast Updated:March 18, 2020Recruiting
Condition(s):Cocaine Dependence; Cocaine Abuse; Cocaine Addiction; Substance AbuseLast Updated:July 27, 2012Completed
Condition(s):OHSSLast Updated:November 17, 2015Unknown status
Condition(s):Ovarian HyperstimulationLast Updated:March 29, 2018Completed
Condition(s):Lactation Suppressed; Cabergoline Adverse Reaction; Postpartum DVT; Postpartum DepressionLast Updated:September 28, 2021Unknown status
Condition(s):OHSSLast Updated:December 27, 2018Completed
Condition(s):Infertility, FemaleLast Updated:June 14, 2021Completed
Condition(s):Recurrent Breast Cancer; Stage IV Breast CancerLast Updated:September 17, 2019Completed
Condition(s):MacroprolactinomaLast Updated:June 14, 2010Unknown status
Condition(s):Ovarian Hyperstimulation SyndromeLast Updated:April 10, 2018Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.